Cargando…
A Novel Aldisine Derivative Exhibits Potential Antitumor Effects by Targeting JAK/STAT3 Signaling
The JAK/STAT3 signaling pathway is aberrantly hyperactivated in many cancers, promoting cell proliferation, survival, invasiveness, and metastasis. Thus, inhibitors targeting JAK/STAT3 have enormous potential for cancer treatment. Herein, we modified aldisine derivatives by introducing the isothiour...
Autores principales: | Wang, Dong-Ping, Wu, Li-Hong, Li, Rui, He, Na, Zhang, Qian-Yue, Zhao, Chen-Yang, Jiang, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141377/ https://www.ncbi.nlm.nih.gov/pubmed/37103357 http://dx.doi.org/10.3390/md21040218 |
Ejemplares similares
-
A Novel Ageladine A Derivative Acts as a STAT3 Inhibitor and Exhibits Potential Antitumor Effects
por: He, Na, et al.
Publicado: (2023) -
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
por: Luo, Wei, et al.
Publicado: (2020) -
Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2
por: Xiong, Xinxin, et al.
Publicado: (2022) -
Design, Synthesis and Structure-Activity Relationship Studies of Meridianin Derivatives as Novel JAK/STAT3 Signaling Inhibitors
por: Zhang, Jian-Qiang, et al.
Publicado: (2022) -
Targeting the tumor microenvironment: JAK-STAT3 signaling
por: Bournazou, Eirini, et al.
Publicado: (2013)